Inventor · disambiguated record
Edmund Idris Graziani
Also filed as: GRAZIANI EDMUND · GRAZIANI EDMUND I · GRAZIANI EDMUND IDRIS
15 granted patents·15 pending applications·198 citations·filing 2004–2022
93Inventor score
Top patents by PatentIndex Score
30 records- 0195US7273874B2Rapamycin derivatives and the uses thereof in the treatment of neurological disordersWYETH CORP·Filed 2005·Granted Sep 25, 2007·35 cites·18 claims
- 0294US8828401B2Cytotoxic peptides and antibody drug conjugates thereofPFIZER·Filed 2012·Granted Sep 9, 2014·35 cites·36 claims
- 0394US7276498B2Rapamycin analogues and uses thereof in the treatment of neurological disordersWYETH CORP·Filed 2005·Granted Oct 2, 2007·24 cites·31 claims
- 0492US7560457B2Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disordersWYETH CORP·Filed 2007·Granted Jul 14, 2009·17 cites·27 claims
- 0592US7019014B2Process for producing anticancer agent LL-D45042WYETH CORP·Filed 2004·Granted Mar 28, 2006·33 cites·3 claims
- 0690US7476678B2Rapamycin derivatives and the uses thereof in the treatment of neurological disordersWYETH CORP·Filed 2007·Granted Jan 13, 2009·14 cites·12 claims
- 0790US7470682B2Rapamycin analogues and the uses thereof in the treatment of neurological disordersWYETH CORP·Filed 2007·Granted Dec 30, 2008·12 cites·20 claims
- 0888US9249186B2Cytotoxic peptides and antibody drug conjugates thereofPFIZER·Filed 2015·Granted Feb 2, 2016·7 cites·5 claims
- 0985US9138486B2Cytotoxic peptides and antibody drug conjugates thereofPFIZER·Filed 2014·Granted Sep 22, 2015·7 cites·29 claims
- 1084US10689458B2Site specific HER2 antibody drug conjugatesPFIZER·Filed 2016·Granted Jun 23, 2020·3 cites·6 claims
- 1182US7247650B2Macrolides and methods for producing sameWYETH CORP·Filed 2005·Granted Jul 24, 2007·9 cites·3 claims
- 1275US11147852B2Engineered antibody constant regions for site-specific conjugation and methods and uses thereforPFIZER·Filed 2012·Granted Oct 19, 2021·1 cites·27 claims
- 1375US7795252B2Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disordersPFIZER·Filed 2009·Granted Sep 14, 2010·1 cites·18 claims
- 1471US2023104503A1Small molecule compoundsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1571US2024350463A1Small molecule compoundsAPERTOR PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1669US2023108125A1Small molecule compoundsAPERTOR PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1769US2024376122A1Small molecule compoundsAPERTOR PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1866US2009203682A1Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological DisordersWYETH CORP·Filed 2008·Application pending·0 cites
- 1963US2010022593A1Process for Producing Anticancer Agent LL-D45042WYETH CORP·Filed 2009·Application pending·0 cites
- 2063US2009088448A1Rapamycin Derivatives and the Uses Thereof in the Treatment of Neurological DisordersWYETH CORP·Filed 2008·Application pending·0 cites
- 2157US2020377615A1Site specific her2 antibody drug conjugatesPFIZER·Filed 2020·Application pending·0 cites
- 2256US8030325B2Biosynthetic gene cluster for the production of a complex polyketideWYETH LLC·Filed 2008·Granted Oct 4, 2011·0 cites·2 claims
- 2354US2020069764A1Antibodies and antibody fragments for site-specific conjugationPFIZER·Filed 2019·Application pending·0 cites
- 2453US2006115879A1Process for producing anticancer agent LL-D45042WYETH CORP·Filed 2006·Application pending·0 cites
- 2552US2007299019A1Macrolides and methods for producing sameWYETH CORP·Filed 2007·Application pending·0 cites
- 2646US7745457B2Meridamycin analogues for the treatment of neurodegenerative disordersWYETH LLC·Filed 2007·Granted Jun 29, 2010·0 cites·29 claims
- 2746US2017216452A1Antibodies and antibody fragments for site-specific conjugationPFIZER·Filed 2016·Application pending·0 cites
- 2844US2011144176A1Macrolides and methods for producing sameWYETH LLC·Filed 2010·Application pending·0 cites
- 2941US2005197356A1Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agentsWYETH CORP·Filed 2005·Application pending·0 cites
- 3041US2010196355A1Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel ActivityWYETH CORP·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Edmund Idris Graziani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →